Global Depression Drug Market published by Variant Market Research is expected to reach $18 billion by 2024 from $15 billion in 2016; growing at a CAGR of 2.6% from 2016 to 2024. By geography, Asia-Pacific and Europe are expected to grow at a CAGR of 3.2% and 2.7%, respectively, during the forecast period.
Get Full Access to This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market
Depression is a medical illness caused by combination of genetics, biological, environment and psychological factors. Several drivers are driving the growth of the global depression drugs market. Key drivers include increasing geriatric population, increasing awareness, growing dependence on medication for controlling the symptoms, and improved efficacy of these drugs.
Though, lack of skilled professionals and social stigma would severely hamper the market development. Additionally, increasing investments in R&D and market expansion would provide several market opportunities in the forecast period.
Get Table of Content (TOC) https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/toc
Product type segment is categorized as Tricyclic Antidepressants, Serotonin-Norepinephrine Inhibitors (SNRIs), Atypical Antipsychotics, Selective Serotonin Reuptake Inhibitors (SSRIs), Benzodiazepines, Tetracyclic Antidepressants (TeCAs), Monoamine Oxidase Inhibitors (MAOIs), and others. Among which, SNRIs dominated the market accounting for more than one fourth of the total depression drugs market share in 2016. Application segments include clinics and hospitals, and research center.
The market by geography is categorized into North America, Europe, Asia-Pacific and Rest of the world. North America accounted for the largest market share of 37.2% in 2016; driven by the increasing number of patients suffering from various kinds of depression and fretfulness disorders. Closely followed by Europe with second largest market with a total share of 32.6%. In terms of growth, Asia-Pacific is anticipated to attain the fastest CAGR of 3.2% during the forecast
period, driven by augmented demand from emerging countries such as China, Japan, and Australia and rising awareness among consumers regarding benefits of depression drug.
The major players in the market include H. Lundbeck, Merck & Co., SK Biopharmaceuticals, Novartis, AstraZeneca, Forest Laboratories, Naurex, GlaxoSmithKline, Eli Lilly and Co., Naurex, and others.
Click Here to Request a Free Sample PDF of This Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/depression-drugs-market/sample-request
Scope of Depression Drugs Market
Product Type Segments
• Tricyclice Antidepressants
• Serotonin-Norepinephrine Inhibitors
• Atypical Antipsychotics
• Selective Serotonin Reuptake Inhibitors
• Benzodiazepines, Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Others
Application Segments
• Clinics and Hospitals
• Research centres
Geographical Segments
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o United Kingdom
o Spain
o Others
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Others
• RoW
o South America
o Middle East
o Africa

About Variant Market Research
Variant Market Research offers syndicated and customized reports to fulfill clients' objectives. We also provide customized data pack proposing market sizing in an Excel/PDF/PowerPoint or Word format as per the requirement of clients. We cover several industry domains, namely Semiconductor & Electronics, Consumer Electronics, Information and Communication Technology, Automotive, Consumer Goods, Food & Beverages, Pharmaceuticals, Medical Devices, Chemicals, Industrial, Mining Equipment, Automation, Manufacturing, Construction, Energy & Power, Defense & Aerospace and Banking, Financial services and Insurance (BFSI). Our expertise are data triangulation, competitor benchmarking, parent market benchmarking, estimating market size and forecast of the market from 2016 to 2024.
For further information, visit https://www.variantmarketresearch.com
You can connect with us on LinkedIn here @ https://www.linkedin.com/company/variant-market-research

Contact Us:
Michael Mendes
Head - Sales
Variant Market Research
649 Mission St, 5th Floor, San Francisco,
CA 94105,United States.
Tel: +1-415-680-2785
Fax: +1-415-680-2786
Email: [email protected]
Email: [email protected]